Gait phenotype from mild cognitive impairment to moderate dementia

Results from the GOOD initiative

G. Allali, C. Annweiler, Helena M. Blumen, M. L. Callisaya, A. M. De Cock, R. W. Kressig, V. Srikanth, J. P. Steinmetz, Joe Verghese, O. Beauchet

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background and purpose: The differences in gait abnormalities from the earliest to the later stages of dementia and in the different subtypes of dementia have not been fully examined. This study aims to compare spatiotemporal gait parameters in cognitively healthy individuals, patients with amnestic mild cognitive impairment (MCI) and non-amnestic MCI, and patients with mild and moderate stages of Alzheimer's disease (AD) and non-Alzheimer's disease (non-AD). Methods: Based on a cross-sectional design, 1719 participants (77.4 ± 7.3 years, 53.9% female) were recruited from cohorts from seven countries participating in the Gait, Cognition and Decline (GOOD) initiative. Mean values and coefficients of variation of spatiotemporal gait parameters were measured during normal pace walking with the GAITRite system at all sites. Results: Performance of spatiotemporal gait parameters declined in parallel with the stage of cognitive decline from MCI status to moderate dementia. Gait parameters of patients with non-amnestic MCI were more disturbed compared to patients with amnestic MCI, and MCI subgroups performed better than demented patients. Patients with non-AD dementia had worse gait performance than those with AD dementia. This degradation of gait parameters was similar between mean values and coefficients of variation of spatiotemporal gait parameters in the earliest stages of cognitive decline, but different in the most advanced stages, especially in the non-AD subtypes. Conclusions: Spatiotemporal gait parameters were more disturbed in the advanced stages of dementia, and more affected in the non-AD dementias than in AD. These findings suggest that quantitative gait parameters could be used as a surrogate marker for improving the diagnosis of dementia.

Original languageEnglish (US)
Pages (from-to)527-541
Number of pages15
JournalEuropean Journal of Neurology
Volume23
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Gait
Cognition
Dementia
Phenotype
Alzheimer Disease
Cognitive Dysfunction
Biomarkers

Keywords

  • Aging
  • Alzheimer's disease
  • Cohort studies
  • Dementia
  • Gait disorders
  • Mild cognitive impairment
  • Motor control
  • Quantitative gait parameters

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Allali, G., Annweiler, C., Blumen, H. M., Callisaya, M. L., De Cock, A. M., Kressig, R. W., ... Beauchet, O. (2016). Gait phenotype from mild cognitive impairment to moderate dementia: Results from the GOOD initiative. European Journal of Neurology, 23(3), 527-541. https://doi.org/10.1111/ene.12882

Gait phenotype from mild cognitive impairment to moderate dementia : Results from the GOOD initiative. / Allali, G.; Annweiler, C.; Blumen, Helena M.; Callisaya, M. L.; De Cock, A. M.; Kressig, R. W.; Srikanth, V.; Steinmetz, J. P.; Verghese, Joe; Beauchet, O.

In: European Journal of Neurology, Vol. 23, No. 3, 01.03.2016, p. 527-541.

Research output: Contribution to journalArticle

Allali, G, Annweiler, C, Blumen, HM, Callisaya, ML, De Cock, AM, Kressig, RW, Srikanth, V, Steinmetz, JP, Verghese, J & Beauchet, O 2016, 'Gait phenotype from mild cognitive impairment to moderate dementia: Results from the GOOD initiative', European Journal of Neurology, vol. 23, no. 3, pp. 527-541. https://doi.org/10.1111/ene.12882
Allali, G. ; Annweiler, C. ; Blumen, Helena M. ; Callisaya, M. L. ; De Cock, A. M. ; Kressig, R. W. ; Srikanth, V. ; Steinmetz, J. P. ; Verghese, Joe ; Beauchet, O. / Gait phenotype from mild cognitive impairment to moderate dementia : Results from the GOOD initiative. In: European Journal of Neurology. 2016 ; Vol. 23, No. 3. pp. 527-541.
@article{746ef0efbf6949b5abc045419d03c66b,
title = "Gait phenotype from mild cognitive impairment to moderate dementia: Results from the GOOD initiative",
abstract = "Background and purpose: The differences in gait abnormalities from the earliest to the later stages of dementia and in the different subtypes of dementia have not been fully examined. This study aims to compare spatiotemporal gait parameters in cognitively healthy individuals, patients with amnestic mild cognitive impairment (MCI) and non-amnestic MCI, and patients with mild and moderate stages of Alzheimer's disease (AD) and non-Alzheimer's disease (non-AD). Methods: Based on a cross-sectional design, 1719 participants (77.4 ± 7.3 years, 53.9{\%} female) were recruited from cohorts from seven countries participating in the Gait, Cognition and Decline (GOOD) initiative. Mean values and coefficients of variation of spatiotemporal gait parameters were measured during normal pace walking with the GAITRite system at all sites. Results: Performance of spatiotemporal gait parameters declined in parallel with the stage of cognitive decline from MCI status to moderate dementia. Gait parameters of patients with non-amnestic MCI were more disturbed compared to patients with amnestic MCI, and MCI subgroups performed better than demented patients. Patients with non-AD dementia had worse gait performance than those with AD dementia. This degradation of gait parameters was similar between mean values and coefficients of variation of spatiotemporal gait parameters in the earliest stages of cognitive decline, but different in the most advanced stages, especially in the non-AD subtypes. Conclusions: Spatiotemporal gait parameters were more disturbed in the advanced stages of dementia, and more affected in the non-AD dementias than in AD. These findings suggest that quantitative gait parameters could be used as a surrogate marker for improving the diagnosis of dementia.",
keywords = "Aging, Alzheimer's disease, Cohort studies, Dementia, Gait disorders, Mild cognitive impairment, Motor control, Quantitative gait parameters",
author = "G. Allali and C. Annweiler and Blumen, {Helena M.} and Callisaya, {M. L.} and {De Cock}, {A. M.} and Kressig, {R. W.} and V. Srikanth and Steinmetz, {J. P.} and Joe Verghese and O. Beauchet",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/ene.12882",
language = "English (US)",
volume = "23",
pages = "527--541",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Gait phenotype from mild cognitive impairment to moderate dementia

T2 - Results from the GOOD initiative

AU - Allali, G.

AU - Annweiler, C.

AU - Blumen, Helena M.

AU - Callisaya, M. L.

AU - De Cock, A. M.

AU - Kressig, R. W.

AU - Srikanth, V.

AU - Steinmetz, J. P.

AU - Verghese, Joe

AU - Beauchet, O.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Background and purpose: The differences in gait abnormalities from the earliest to the later stages of dementia and in the different subtypes of dementia have not been fully examined. This study aims to compare spatiotemporal gait parameters in cognitively healthy individuals, patients with amnestic mild cognitive impairment (MCI) and non-amnestic MCI, and patients with mild and moderate stages of Alzheimer's disease (AD) and non-Alzheimer's disease (non-AD). Methods: Based on a cross-sectional design, 1719 participants (77.4 ± 7.3 years, 53.9% female) were recruited from cohorts from seven countries participating in the Gait, Cognition and Decline (GOOD) initiative. Mean values and coefficients of variation of spatiotemporal gait parameters were measured during normal pace walking with the GAITRite system at all sites. Results: Performance of spatiotemporal gait parameters declined in parallel with the stage of cognitive decline from MCI status to moderate dementia. Gait parameters of patients with non-amnestic MCI were more disturbed compared to patients with amnestic MCI, and MCI subgroups performed better than demented patients. Patients with non-AD dementia had worse gait performance than those with AD dementia. This degradation of gait parameters was similar between mean values and coefficients of variation of spatiotemporal gait parameters in the earliest stages of cognitive decline, but different in the most advanced stages, especially in the non-AD subtypes. Conclusions: Spatiotemporal gait parameters were more disturbed in the advanced stages of dementia, and more affected in the non-AD dementias than in AD. These findings suggest that quantitative gait parameters could be used as a surrogate marker for improving the diagnosis of dementia.

AB - Background and purpose: The differences in gait abnormalities from the earliest to the later stages of dementia and in the different subtypes of dementia have not been fully examined. This study aims to compare spatiotemporal gait parameters in cognitively healthy individuals, patients with amnestic mild cognitive impairment (MCI) and non-amnestic MCI, and patients with mild and moderate stages of Alzheimer's disease (AD) and non-Alzheimer's disease (non-AD). Methods: Based on a cross-sectional design, 1719 participants (77.4 ± 7.3 years, 53.9% female) were recruited from cohorts from seven countries participating in the Gait, Cognition and Decline (GOOD) initiative. Mean values and coefficients of variation of spatiotemporal gait parameters were measured during normal pace walking with the GAITRite system at all sites. Results: Performance of spatiotemporal gait parameters declined in parallel with the stage of cognitive decline from MCI status to moderate dementia. Gait parameters of patients with non-amnestic MCI were more disturbed compared to patients with amnestic MCI, and MCI subgroups performed better than demented patients. Patients with non-AD dementia had worse gait performance than those with AD dementia. This degradation of gait parameters was similar between mean values and coefficients of variation of spatiotemporal gait parameters in the earliest stages of cognitive decline, but different in the most advanced stages, especially in the non-AD subtypes. Conclusions: Spatiotemporal gait parameters were more disturbed in the advanced stages of dementia, and more affected in the non-AD dementias than in AD. These findings suggest that quantitative gait parameters could be used as a surrogate marker for improving the diagnosis of dementia.

KW - Aging

KW - Alzheimer's disease

KW - Cohort studies

KW - Dementia

KW - Gait disorders

KW - Mild cognitive impairment

KW - Motor control

KW - Quantitative gait parameters

UR - http://www.scopus.com/inward/record.url?scp=84959267091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959267091&partnerID=8YFLogxK

U2 - 10.1111/ene.12882

DO - 10.1111/ene.12882

M3 - Article

VL - 23

SP - 527

EP - 541

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 3

ER -